ANKON Medical Technologies   Report issue

For profit Phase 4
Founded: Wuhan China (2009)
Status: Left NME R&D (2017)

Organization Overview

First Clinical Trial
2017
NCT03198741
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

ANKON medical technologies (Shanghai)Co.,LTD

Active Ingredients

Drugs in Phase 4 Trials (2)

acetylsalicylic acid (aspirin) (1 trial)

clopidogrel (plavix) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 4)

Heart Diseases (Phase 4)

Myocardial Ischemia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2